Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease

被引:27
|
作者
Zekonyte, Jurgita [1 ]
Sakai, Kenji [2 ]
Nicoll, James A. R. [3 ]
Weller, Roy O. [3 ]
Carare, Roxana O. [3 ]
机构
[1] Univ Southampton, Fac Engn & Environm, Southampton SO9 5NH, Hants, England
[2] Kanazawa Univ Hosp, Dept Neurol, Kanazawa, Ishikawa, Japan
[3] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England
基金
英国生物技术与生命科学研究理事会; 英国工程与自然科学研究理事会;
关键词
Apolipoprotein E; Perivascular clearance pathways; Laminin; Atomic force microscopy; Amyloid-beta; Cerebral amyloid angiopathy; Alzheimer's disease; ISOFORM-SPECIFIC BINDING; APOLIPOPROTEIN-E; FORCE SPECTROSCOPY; ANGIOPATHY; PROTEIN; BRAIN; ATTACHMENT; CLEARANCE; DRAINAGE; REMOVAL;
D O I
10.1016/j.bbadis.2015.08.025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Accumulation of amyloid-beta (A beta) in plaques in the brain and in artery walls as cerebral amyloid angiopathy indicates a failure of elimination of A beta from the brain with age and Alzheimer's disease. A major pathway for elimination of A beta and other soluble metabolites from the brain is along basement membranes within the walls of cerebral arteries that represent the lymphatic drainage pathways for the brain. The motive force for the elimination of A beta along this perivascular pathway appears to be the contrary (reflection) wave that follows the arterial pulse wave. Following injection into brain parenchyma, A beta rapidly drains out of the brain along basement membranes in the walls of cerebral arteries; such drainage is impaired in apolipoprotein E epsilon 4 (ApoE4) mice. For drainage of A beta to occur in a direction contrary to the pulse wave, some form of attachment to basement membrane would be required to prevent reflux of A beta back into the brain during the passage of the subsequent pulse wave. In this study, we show first that apolipoprotein E co-localizes with A beta in basement membrane drainage pathways in the walls of arteries. Secondly, we show by Atomic Force Microscopy that attachment of ApoE4/A beta complexes to basement membrane laminin is significantly weaker than ApoE3/A beta complexes. These results suggest that perivascular elimination of ApoE4/A beta complexes would be less efficient than with other isoforms of apolipoprotein E, thus endowing a higher risk for Alzheimer's disease. Therapeutic correction for ApoE4/A beta/laminin interactions may increase the efficiency of elimination of A beta in the prevention of Alzheimer's disease. This article is part of a Special Issue entitled: Vascular Contributions to Cognitive Impairment and Dementia edited by M. Paul Murphy, Roderick A. Corriveau and Donna M. Wilcock. (c) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:1047 / 1053
页数:7
相关论文
共 50 条
  • [21] Molecular and Therapeutic Targets for Amyloid-beta Plaques in Alzheimer's Disease: A Review Study
    Thomas, Jaya
    Wilson, Samson
    BASIC AND CLINICAL NEUROSCIENCE, 2024, 15 (01) : 1 - 26
  • [22] Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer’s Disease
    Chuan He
    Zhong-sheng Huang
    Chao-chao Yu
    Hai-hua Wang
    Hua Zhou
    Li-hong Kong
    Current Medical Science, 2020, 40 : 1022 - 1030
  • [23] Amyloid-beta and tau protein beyond Alzheimer's disease
    Morteza Abyadeh
    Vivek Gupta
    Joao A.Paulo
    Arezoo Gohari Mahmoudabad
    Sina Shadfar
    Shahab Mirshahvaladi
    Veer Gupta
    Christine T.O.Nguyen
    David I.Finkelstein
    Yuyi You
    Paul A.Haynes
    Ghasem H.Salekdeh
    Stuart L.Graham
    Mehdi Mirzaei
    Neural Regeneration Research, 2024, (06) : 1262 - 1276
  • [24] RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
    Yan, SD
    Chen, X
    Fu, J
    Chen, M
    Zhu, HJ
    Roher, A
    Slattery, T
    Zhao, L
    Nagashima, M
    Morser, J
    Migheli, A
    Nawroth, P
    Stern, D
    Schmidt, AM
    NATURE, 1996, 382 (6593) : 685 - 691
  • [25] Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain
    Wildburger, Norelle C.
    Esparza, Thomas J.
    LeDuc, Richard D.
    Fellers, Ryan T.
    Thomas, Paul M.
    Cairns, Nigel J.
    Kelleher, Neil L.
    Bateman, Randall J.
    Brody, David L.
    SCIENTIFIC REPORTS, 2017, 7
  • [26] Innate immunity and amyloid-beta clearance in Alzheimer's disease
    Fiala, M
    Chiappelli, F
    Graves, MC
    NEUROBIOLOGY OF AGING, 2004, 25 : S533 - S533
  • [27] Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer’s disease
    Evan Dorey
    Nina Chang
    Qing Yan Liu
    Ze Yang
    Wandong Zhang
    Neuroscience Bulletin, 2014, 30 : 317 - 330
  • [28] Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain
    Norelle C. Wildburger
    Thomas J. Esparza
    Richard D. LeDuc
    Ryan T. Fellers
    Paul M. Thomas
    Nigel J. Cairns
    Neil L. Kelleher
    Randall J. Bateman
    David L. Brody
    Scientific Reports, 7
  • [29] Amyloid-beta and tau protein beyond Alzheimer's disease
    Abyadeh, Morteza
    Gupta, Vivek
    Paulo, Joao A.
    Mahmoudabad, Arezoo Gohari
    Shadfar, Sina
    Mirshahvaladi, Shahab
    Gupta, Veer
    Nguyen, Christine T. O.
    Finkelstein, David I.
    You, Yuyi
    Haynes, Paul A.
    Salekdeh, Ghasem H.
    Graham, Stuart L.
    Mirzaei, Mehdi
    NEURAL REGENERATION RESEARCH, 2024, 19 (06) : 1262 - 1276
  • [30] Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease
    Dorey, Evan
    Chang, Nina
    Liu, Qing Yan
    Yang, Ze
    Zhang, Wandong
    NEUROSCIENCE BULLETIN, 2014, 30 (02) : 317 - 330